SlideShare a Scribd company logo
1 of 6
2018 || Pharmaceuticals || Leukemia
Therapeutics Market to 2018 – Strong ||
Aarkstore.com


http://www.aarkstore.com/reports/Leukemia-Therapeutics-Market-to-
2018-Strong-Late-stage-Pipeline-to-Sustain-Branded-Drugs-Major-Market-
Share-230019.html




       You can also request for sample page of above
       mention reports on sample@aarkstore.com
Description


GBI Research, the leading business intelligence provider, has released its latest
research “Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to
Sustain Branded Drugs' Major Market Share” which provides insights into
leukemia therapeutics market until 2018 for four major indications. The report
is built using data and information sourced from proprietary databases, primary
and secondary research and in-house analysis by GBI Research’s team of
industry experts.

The report provides an in-depth analysis of the major leukemia indications
including acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia
(CLL), acute myelocytic leukemia (AML) and chronic myelocytic leukemia
(CML). The report examines the global leukemia diseases treatment usage
patterns. In addition, the geographical distribution of leukemia therapeutics and
markets across the US, the top five countries of Europe and in Japan are
provided in the report. The report also includes insights into the leukemia
therapeutics R&D product pipeline and explores the competitive landscape
including major players in the leukemia therapeutics market. Finally, the report
also includes analysis on Mergers and Acquisitions (M&As) and licensing
agreements that took place in leukemia therapeutics market.
Scope

- Data and analysis on the leukemia therapeutics market in the leading
geographies of the world – the US, Japan, the UK, Germany, France, Italy and
Spain
 - Annualized market data for the leukemia therapeutics market from 2004 to
2011, with forecasts to 2018
 - Market data on the geographical landscape and therapeutic landscape,
including market size, market share, annual cost of therapy, sales volume and
treatment usage patterns such as disease population, treatment seeking
population, diagnosis population and prescription population

Reasons to buy

- Align your product portfolio to the markets with high growth potential.
- Build effective strategies to launch their pipeline products by identifying
potential geographies.
- Exploit in-licensing and out-licensing opportunities by identifying products that
might fill their portfolio gaps.
Table of Contents :

1.1 List of Tables 8
 1.2 List of Figures 10
 2 Leukemia Market to 2018 - Introduction 12
 3 Leukemia Market to 2018 - Market Overview 13
 3.1 Introduction 13
 3.1.1 Revenue 13
 3.1.2 Annual Cost of Treatment 15
 3.1.3 Treatment Usage Pattern 16
 3.2 Drivers and Barriers 18
 3.2.1 Drivers for the Leukemia Therapeutics Market 18
 3.2.2 Barriers for the Leukemia Therapeutics Market 19
 4 Leukemia Market to 2018 - Geographical Landscape 20
 4.1 Revenue Analysis by Geography 20
 4.2 The US 22
 4.2.1 Revenue 22
 4.2.2 Annual Cost of Therapy 23
 4.2.3 Treatment Usage Pattern 24
 4.3 Top Five Countries of Europe 26…………..
More Latest Reports:

E-waste Management Market to 2020 - Expansion of Domestic Electronics
Sector to Drive Asia Pacific Growth Despite Ban on Illegal Exports from
Developed Countries

Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to
Sustain Branded Drugs' Major Market Share

Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents
Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and
Ulcerative Colitis (UC) to Reinvigorate the Market

Butadiene Europe and Middle East Market to 2020 - North American
Supply Shortages to Drive European Exports

Downstream Processing in Biopharmaceuticals - Adoption of Disposable
Technology at Improved Economies of Scale to Optimize Production
Efficiency and Cost-effectiveness
For More details about above & other Reports
plz contact :



Lavanya
Aarkstore.com
Contact: Marketing team
Mob.No.918149852585
Email: enquiry@aarkstore.com ,
discount@aarkstore.com
URL: http://www.aarkstore.com/
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore

More Related Content

More from Rose088

Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricantsRose088
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Rose088
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Rose088
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Rose088
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Rose088
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Rose088
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Rose088
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Rose088
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Rose088
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Rose088
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Rose088
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Rose088
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Rose088
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012Rose088
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asiaRose088
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchRose088
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Rose088
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Rose088
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Rose088
 

More from Rose088 (20)

Chinese markets for industrial lubricants
Chinese markets for industrial lubricantsChinese markets for industrial lubricants
Chinese markets for industrial lubricants
 
Mumbai
MumbaiMumbai
Mumbai
 
Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012Zydus cadila healthcare limited – product pipeline review – 2012
Zydus cadila healthcare limited – product pipeline review – 2012
 
Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012Ziopharm oncology, inc. – product pipeline review – 2012
Ziopharm oncology, inc. – product pipeline review – 2012
 
Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012Topo target a s – product pipeline review – 2012
Topo target a s – product pipeline review – 2012
 
Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012Macro genics, inc. – product pipeline review – 2012
Macro genics, inc. – product pipeline review – 2012
 
Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012Ym bio sciences inc. – product pipeline review – 2012
Ym bio sciences inc. – product pipeline review – 2012
 
Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012Astrocytoma – pipeline review, h2 2012
Astrocytoma – pipeline review, h2 2012
 
Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012Ipsen inc. – product pipeline review – 2012
Ipsen inc. – product pipeline review – 2012
 
Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012Methyl gene inc – product pipeline review – 2012
Methyl gene inc – product pipeline review – 2012
 
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
Mer lion pharmaceuticals pte ltd – product pipeline review – 2012
 
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012Glenmark pharmaceuticals ltd. – product pipeline review – 2012
Glenmark pharmaceuticals ltd. – product pipeline review – 2012
 
Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012Geron corporation – product pipeline review – 2012
Geron corporation – product pipeline review – 2012
 
Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012Immuno gen, inc. – product pipeline review – 2012
Immuno gen, inc. – product pipeline review – 2012
 
7 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 20127 tm pharma as – product pipeline review – 2012
7 tm pharma as – product pipeline review – 2012
 
Emerging power markets in south east asia
Emerging power markets in south east asiaEmerging power markets in south east asia
Emerging power markets in south east asia
 
Cloud computing in pharmaceutical research
Cloud computing in pharmaceutical researchCloud computing in pharmaceutical research
Cloud computing in pharmaceutical research
 
Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012Shire plc – product pipeline review – 2012
Shire plc – product pipeline review – 2012
 
Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012Mundipharma international limited – product pipeline review – 2012
Mundipharma international limited – product pipeline review – 2012
 
Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012Actelion ltd – product pipeline review – 2012
Actelion ltd – product pipeline review – 2012
 

Leukemia therapeutics market to 2018 strong

  • 1. 2018 || Pharmaceuticals || Leukemia Therapeutics Market to 2018 – Strong || Aarkstore.com http://www.aarkstore.com/reports/Leukemia-Therapeutics-Market-to- 2018-Strong-Late-stage-Pipeline-to-Sustain-Branded-Drugs-Major-Market- Share-230019.html You can also request for sample page of above mention reports on sample@aarkstore.com
  • 2. Description GBI Research, the leading business intelligence provider, has released its latest research “Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share” which provides insights into leukemia therapeutics market until 2018 for four major indications. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of the major leukemia indications including acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelocytic leukemia (AML) and chronic myelocytic leukemia (CML). The report examines the global leukemia diseases treatment usage patterns. In addition, the geographical distribution of leukemia therapeutics and markets across the US, the top five countries of Europe and in Japan are provided in the report. The report also includes insights into the leukemia therapeutics R&D product pipeline and explores the competitive landscape including major players in the leukemia therapeutics market. Finally, the report also includes analysis on Mergers and Acquisitions (M&As) and licensing agreements that took place in leukemia therapeutics market.
  • 3. Scope - Data and analysis on the leukemia therapeutics market in the leading geographies of the world – the US, Japan, the UK, Germany, France, Italy and Spain - Annualized market data for the leukemia therapeutics market from 2004 to 2011, with forecasts to 2018 - Market data on the geographical landscape and therapeutic landscape, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population, treatment seeking population, diagnosis population and prescription population Reasons to buy - Align your product portfolio to the markets with high growth potential. - Build effective strategies to launch their pipeline products by identifying potential geographies. - Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps.
  • 4. Table of Contents : 1.1 List of Tables 8 1.2 List of Figures 10 2 Leukemia Market to 2018 - Introduction 12 3 Leukemia Market to 2018 - Market Overview 13 3.1 Introduction 13 3.1.1 Revenue 13 3.1.2 Annual Cost of Treatment 15 3.1.3 Treatment Usage Pattern 16 3.2 Drivers and Barriers 18 3.2.1 Drivers for the Leukemia Therapeutics Market 18 3.2.2 Barriers for the Leukemia Therapeutics Market 19 4 Leukemia Market to 2018 - Geographical Landscape 20 4.1 Revenue Analysis by Geography 20 4.2 The US 22 4.2.1 Revenue 22 4.2.2 Annual Cost of Therapy 23 4.2.3 Treatment Usage Pattern 24 4.3 Top Five Countries of Europe 26…………..
  • 5. More Latest Reports: E-waste Management Market to 2020 - Expansion of Domestic Electronics Sector to Drive Asia Pacific Growth Despite Ban on Illegal Exports from Developed Countries Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market Butadiene Europe and Middle East Market to 2020 - North American Supply Shortages to Drive European Exports Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness
  • 6. For More details about above & other Reports plz contact : Lavanya Aarkstore.com Contact: Marketing team Mob.No.918149852585 Email: enquiry@aarkstore.com , discount@aarkstore.com URL: http://www.aarkstore.com/ http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstore